中民控股(00681.HK):全年實現收入17.48億元
格隆匯 4 月 26日丨中民控股(00681.HK)公佈截至2020年12月31日止9個月全年業績,報吿期間,集團收入約人民幣17.48億元(過往年度:人民幣22.33億元);溢利約人民幣1.45億元(過往年度:人民幣2.17億元);每股基本盈利為人民幣1.21分(過往年度:人民幣2.04分);不建議派付末期股息(過往年度:無)。
截至該報吿9個月期間,集團的整體毛利率約為16.40%(過往年度:17.14%),較過往年度減了 0.74個百分點。毛利率下跌主要原因,因毛利較低的燃氣分銷業務收入所佔的比例較過往年度上升,而毛利較高的管道燃氣輸配業務及罐裝燃氣供應業務收入所佔的比例下降所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.